Cargando…
Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action.
Polyalkylcyanoacrylate (PACA) nanoparticles loaded with doxorubicin allowed multidrug resistance to be overcome in vitro. However, increased cytotoxicity is not always correlated with an increased level of intracellular drug. Although we have previously shown that PACA nanoparticles are not endocyto...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1997
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223924/ https://www.ncbi.nlm.nih.gov/pubmed/9231919 |
_version_ | 1782149450585604096 |
---|---|
author | de Verdière, A. C. Dubernet, C. Némati, F. Soma, E. Appel, M. Ferté, J. Bernard, S. Puisieux, F. Couvreur, P. |
author_facet | de Verdière, A. C. Dubernet, C. Némati, F. Soma, E. Appel, M. Ferté, J. Bernard, S. Puisieux, F. Couvreur, P. |
author_sort | de Verdière, A. C. |
collection | PubMed |
description | Polyalkylcyanoacrylate (PACA) nanoparticles loaded with doxorubicin allowed multidrug resistance to be overcome in vitro. However, increased cytotoxicity is not always correlated with an increased level of intracellular drug. Although we have previously shown that PACA nanoparticles are not endocytosed by tumour cells, we report here that a direct interaction between nanoparticles and cells is a necessary requirement for overcoming resistance. In addition, the results showed that the degradation products of PACA (mainly polycyanoacrylic acid) in the presence of doxorubicin are able to increase both accumulation and cytotoxicity, thus suggesting the formation of a doxorubicin-polycyanoacrylic acid ion pair. It is therefore concluded that resistance is overcome as a result of both the adsorption of nanoparticles to the cell surface and increased doxorubicin diffusion by the accumulation of an ion pair at the plasma membrane. |
format | Text |
id | pubmed-2223924 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1997 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-22239242009-09-10 Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. de Verdière, A. C. Dubernet, C. Némati, F. Soma, E. Appel, M. Ferté, J. Bernard, S. Puisieux, F. Couvreur, P. Br J Cancer Research Article Polyalkylcyanoacrylate (PACA) nanoparticles loaded with doxorubicin allowed multidrug resistance to be overcome in vitro. However, increased cytotoxicity is not always correlated with an increased level of intracellular drug. Although we have previously shown that PACA nanoparticles are not endocytosed by tumour cells, we report here that a direct interaction between nanoparticles and cells is a necessary requirement for overcoming resistance. In addition, the results showed that the degradation products of PACA (mainly polycyanoacrylic acid) in the presence of doxorubicin are able to increase both accumulation and cytotoxicity, thus suggesting the formation of a doxorubicin-polycyanoacrylic acid ion pair. It is therefore concluded that resistance is overcome as a result of both the adsorption of nanoparticles to the cell surface and increased doxorubicin diffusion by the accumulation of an ion pair at the plasma membrane. Nature Publishing Group 1997 /pmc/articles/PMC2223924/ /pubmed/9231919 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article de Verdière, A. C. Dubernet, C. Némati, F. Soma, E. Appel, M. Ferté, J. Bernard, S. Puisieux, F. Couvreur, P. Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. |
title | Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. |
title_full | Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. |
title_fullStr | Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. |
title_full_unstemmed | Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. |
title_short | Reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. |
title_sort | reversion of multidrug resistance with polyalkylcyanoacrylate nanoparticles: towards a mechanism of action. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223924/ https://www.ncbi.nlm.nih.gov/pubmed/9231919 |
work_keys_str_mv | AT deverdiareac reversionofmultidrugresistancewithpolyalkylcyanoacrylatenanoparticlestowardsamechanismofaction AT dubernetc reversionofmultidrugresistancewithpolyalkylcyanoacrylatenanoparticlestowardsamechanismofaction AT namatif reversionofmultidrugresistancewithpolyalkylcyanoacrylatenanoparticlestowardsamechanismofaction AT somae reversionofmultidrugresistancewithpolyalkylcyanoacrylatenanoparticlestowardsamechanismofaction AT appelm reversionofmultidrugresistancewithpolyalkylcyanoacrylatenanoparticlestowardsamechanismofaction AT fertaj reversionofmultidrugresistancewithpolyalkylcyanoacrylatenanoparticlestowardsamechanismofaction AT bernards reversionofmultidrugresistancewithpolyalkylcyanoacrylatenanoparticlestowardsamechanismofaction AT puisieuxf reversionofmultidrugresistancewithpolyalkylcyanoacrylatenanoparticlestowardsamechanismofaction AT couvreurp reversionofmultidrugresistancewithpolyalkylcyanoacrylatenanoparticlestowardsamechanismofaction |